# PROphylaxis in NOn Major Orthopaedic Surgery

> **NCT02401594** · PHASE3 · TERMINATED · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 3608 (actual)

## Conditions studied

- Non-major Orthopaedic Surgery

## Interventions

- **DRUG:** Rivaroxaban
- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT02401594
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-12-08
- **Primary completion:** 2018-04-11
- **Final completion:** 2018-04-16
- **Target enrollment:** 3608 (ACTUAL)
- **Why stopped:** Remaining outdated treatments and additional costs too high for new manufacturing
- **Last updated:** 2018-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02401594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02401594, "PROphylaxis in NOn Major Orthopaedic Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02401594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*